Literature DB >> 18836065

Does occult hepatitis C virus infection exist?

Vicente Carreño, Javier Bartolomé, Inmaculada Castillo, Juan Antonio Quiroga.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18836065      PMCID： PMC2566113          DOI： 10.1128/JCM.01148-08

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  20 in total

1.  Effects of delayed freezing of liver biopsies on the detection of hepatitis C virus RNA strands.

Authors:  A Madejón; M L Manzano; C Arocena; I Castillo; V Carreño
Journal:  J Hepatol       Date:  2000-06       Impact factor: 25.083

2.  HCV viral load in anti-HCV-reactive donors and infectivity for their recipients.

Authors:  Eva A Operskalski; James W Mosley; Leslie H Tobler; Eberhard W Fiebig; Marek J Nowicki; Larry T Mimms; James Gallarda; Bruce H Phelps; Michael P Busch
Journal:  Transfusion       Date:  2003-10       Impact factor: 3.157

3.  Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C.

Authors:  Marek Radkowski; Juan F Gallegos-Orozco; Joanna Jablonska; Thomas V Colby; Bozena Walewska-Zielecka; Joanna Kubicka; Jeffrey Wilkinson; Debra Adair; Jorge Rakela; Tomasz Laskus
Journal:  Hepatology       Date:  2005-01       Impact factor: 17.425

4.  Quantitative analysis of hepatitis C virus in peripheral blood and liver: replication detected only in liver.

Authors:  J Boisvert; X S He; R Cheung; E B Keeffe; T Wright; H B Greenberg
Journal:  J Infect Dis       Date:  2001-08-30       Impact factor: 5.226

5.  Impact of various handling and storage conditions on quantitative detection of hepatitis C virus RNA.

Authors:  P Halfon; H Khiri; V Gerolami; M Bourliere; J M Feryn; P Reynier; A Gauthier; G Cartouzou
Journal:  J Hepatol       Date:  1996-09       Impact factor: 25.083

6.  Specific detection of minus-strand hepatitis C virus RNA by reverse-transcription polymerase chain reaction on PolyA(+)-purified RNA.

Authors:  S T Takyar; D s Li; Y h Wang; R Trowbridge; E J Gowans
Journal:  Hepatology       Date:  2000-08       Impact factor: 17.425

7.  Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study.

Authors:  L B Seeff; F B Hollinger; H J Alter; E C Wright; C M Cain; Z J Buskell; K G Ishak; F L Iber; D Toro; A Samanta; R L Koretz; R P Perrillo; Z D Goodman; R G Knodell; G Gitnick; T R Morgan; E R Schiff; S Lasky; C Stevens; R Z Vlahcevic; E Weinshel; T Tanwandee; H J Lin; L Barbosa
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

8.  Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C.

Authors:  Tram N Q Pham; Sonya A MacParland; Patricia M Mulrooney; Helen Cooksley; Nikolai V Naoumov; Tomasz I Michalak
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

9.  Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown.

Authors:  Inmaculada Castillo; Margarita Pardo; Javier Bartolomé; Nuria Ortiz-Movilla; Elena Rodríguez-Iñigo; Susana de Lucas; Clara Salas; Jose A Jiménez-Heffernan; Arturo Pérez-Mota; Javier Graus; Juan Manuel López-Alcorocho; Vicente Carreño
Journal:  J Infect Dis       Date:  2003-12-31       Impact factor: 5.226

10.  Hepatocellular carcinoma in a patient with liver cirrhosis associated with negative serum HCV tests but positive liver tissue HCV RNA.

Authors:  Tomoka Esaki; Norihisa Suzuki; Keiji Yokoyama; Kaoru Iwata; Makoto Irie; Akira Anan; Hidetoshi Nakane; Makoto Yoshikane; Shinya Nishizawa; Syuichi Ueda; Tetsuro Sohda; Hiroshi Watanabe; Shotaro Sakisaka
Journal:  Intern Med       Date:  2004-04       Impact factor: 1.271
View more
  1 in total

1.  Prevalence and risk factors of Occult Hepatitis C infections in blood donors from Mexico City.

Authors:  María de la Luz Martínez-Rodríguez; Luis A Uribe-Noguez; Carla I Arroyo-Anduiza; José Antonio Mata-Marin; Gamaliel Benitez-Arvizu; María L Portillo-López; Alicia Ocaña-Mondragón
Journal:  PLoS One       Date:  2018-10-19       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.